ROSANNARandomized Study to Assess Colonic Microbiota Changes in Response to Energy Drink Consumption
Energy drink
Colonic Diseases+8
+ Digestive System Diseases
+ Digestive System Neoplasms
Basic Science Study
Summary
Study start date: February 28, 2024
Actual date on which the first participant was enrolled.This study is focused on understanding how drinking energy drinks might change the bacteria in the gut, potentially increasing the risk of colorectal cancer, especially in younger adults. Colorectal cancer is a major health concern, and the rates are rising in individuals under 50 years old. Researchers are exploring if high taurine levels in energy drinks could promote certain gut bacteria that produce hydrogen sulfide, a compound that may contribute to cancer development. By exploring this connection, the study aims to uncover new ways to prevent or manage early-onset colorectal cancer. Participants in the study will consume energy drinks, and researchers will monitor changes in their gut bacteria. The study will check if the taurine in energy drinks encourages the growth of hydrogen sulfide-producing bacteria. The results will help determine if there is a significant increase in these bacteria, which could be linked to higher cancer risk. Understanding these changes is crucial for developing potential strategies to reduce colorectal cancer risk associated with diet and lifestyle factors.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.76 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Basic Science Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 40 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location